← Back to all trials
Not Yet Recruiting
NCT07656558
ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
Conditions: SCHIZOPHRENIA 1 (Disorder)
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 60
Sponsor: Aydin Adnan Menderes University
Location: Nevşehir State Hospital Community Mental Health Center Nevşehir Merkez
Summary
This randomized controlled trial aims to examine the effects of an Acceptance and Commitment Therapy (ACT)-based psychoeducation program on expressed emotion, perceived family burden, and psychological flexibility among caregivers of patients with schizophrenia attending a Community Mental Health Center.
The main questions this study aims to answer are:
* Does ACT-based psychoeducation reduce expressed emotion among caregivers of patients with schizophrenia?
* Does ACT-based psychoeducation reduce perceived family burden among caregivers of patients with schizophrenia?
* Does ACT-based psychoeducation improve psychological flexibility among caregivers of patients with schizophrenia?
Researchers will randomly assign eligible caregivers to either an intervention group receiving an 8-session ACT-based psychoeducation program or a control group receiving routine care.
Participants will:
* Complete assessment measures before the intervention (pre-test).
* Participate in 8 ACT-based psychoeducation sessions if assigned to the intervention group.
* Continue receiving routine care if assigned to the control group.
* Complete assessment measures immediately after the intervention (post-test).
* Complete follow-up assessments at 1 month and 3 months after the intervention.
Eligibility Criteria
Inclusion Criteria:
* Living with an individual diagnosed with schizophrenia who has been followed and actively receiving services from a Community Mental Health Center for at least one year.
* Being the primary caregiver responsible for the care of the individual diagnosed with schizophrenia.
* Having been involved in the care and treatment of the individual diagnosed with schizophrenia for at least 12 months prior to the study.
* Being between 18 and 65 years of age.
* Being literate.
* Being able to speak and understand Turkish.
* Willing to participate in the study and providing informed consent.
Exclusion Criteria:
* Having a medically diagnosed psychiatric disorder.
* Having a diagnosis of an organic mental disorder or intellectual disability.
* Having a physical impairment that may interfere with participation in the study or data collection process (e.g., hearing or speech impairment).
Source: ClinicalTrials.gov (NCT07656558). StuddyBuddy aggregates publicly available trial information.